Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Folic acid-dependent pathways" comprise a network of biochemical processes critical for transferring one-carbon units required for the synthesis of nucleotides, certain amino acids, and methylation reactions. These pathways rely on multiple enzymes (e.g., dihydrofolate reductase, methionine synthase), receptors (folate receptor alpha, beta, gamma), and transporters to metabolize and utilize folic acid and its derivatives. Disruption or inhibition of these pathways can result in cell cycle arrest, anemia, developmental defects, and increased risk for cancer and cardiovascular disease. While specific proteins within these pathways are considered drug targets, the label "folic acid-dependent pathways" refers to a process rather than a single molecular entity; therefore, it is not a canonical name for a therapeutic drug target.
Enzyme inhibition (antifolates inhibit dihydrofolate reductase, thymidylate synthase, others, blocking nucleotide synthesis); Competitive inhibition of folate transporters or receptors; Interference with one-carbon transfer and methylation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Folic acid-dependent pathways.